Sodium valproate induced hyperammonaemia without hepatic failure in adults

A series of three cases

Vybhav Krishna, Sereen Rose Thomson, Bharti Chogtu, Ganga Parameshwari Soundarrajan, P. S.V.N. Sharma

Research output: Contribution to journalArticle

Abstract

Valproate is an antiepileptic drug that is most commonly prescribed because of its wide spectrum of antiepileptic activity. It is used for the treatment of many psychiatric conditions such as bipolar disorder, schizoaffective disorder, social phobias etc. Valproate is associated with modest elevation of plasma ammonia levels. Some of the risk factors associated with this are poor nutritional intake, antiepileptic polypharmacy, febrile conditions which are thought to deplete L-carnitine levels. Hence, it is important to monitor the plasma ammonia levels at intervals before the patient could develop hyperammonaemic encephalopathy. We hereby report a series of three cases of patients who developed hyperammonaemia following the intake of sodium valproate.

Original languageEnglish
Pages (from-to)FR01-FR02
JournalJournal of Clinical and Diagnostic Research
Volume12
Issue number2
DOIs
Publication statusPublished - 01-02-2018

Fingerprint

Hyperammonemia
Liver Failure
Valproic Acid
Anticonvulsants
Ammonia
Plasmas
Polypharmacy
Carnitine
Brain Diseases
Bipolar Disorder
Psychotic Disorders
Psychiatry
Fever
Therapeutics

All Science Journal Classification (ASJC) codes

  • Clinical Biochemistry

Cite this

Krishna, Vybhav ; Thomson, Sereen Rose ; Chogtu, Bharti ; Soundarrajan, Ganga Parameshwari ; Sharma, P. S.V.N. / Sodium valproate induced hyperammonaemia without hepatic failure in adults : A series of three cases. In: Journal of Clinical and Diagnostic Research. 2018 ; Vol. 12, No. 2. pp. FR01-FR02.
@article{17e38dd7ba864d408ad3105ab732d322,
title = "Sodium valproate induced hyperammonaemia without hepatic failure in adults: A series of three cases",
abstract = "Valproate is an antiepileptic drug that is most commonly prescribed because of its wide spectrum of antiepileptic activity. It is used for the treatment of many psychiatric conditions such as bipolar disorder, schizoaffective disorder, social phobias etc. Valproate is associated with modest elevation of plasma ammonia levels. Some of the risk factors associated with this are poor nutritional intake, antiepileptic polypharmacy, febrile conditions which are thought to deplete L-carnitine levels. Hence, it is important to monitor the plasma ammonia levels at intervals before the patient could develop hyperammonaemic encephalopathy. We hereby report a series of three cases of patients who developed hyperammonaemia following the intake of sodium valproate.",
author = "Vybhav Krishna and Thomson, {Sereen Rose} and Bharti Chogtu and Soundarrajan, {Ganga Parameshwari} and Sharma, {P. S.V.N.}",
year = "2018",
month = "2",
day = "1",
doi = "10.7860/JCDR/2018/30892.11221",
language = "English",
volume = "12",
pages = "FR01--FR02",
journal = "Journal of Clinical and Diagnostic Research",
issn = "2249-782X",
publisher = "Journal of Clinical and Diagnostic Research",
number = "2",

}

Sodium valproate induced hyperammonaemia without hepatic failure in adults : A series of three cases. / Krishna, Vybhav; Thomson, Sereen Rose; Chogtu, Bharti; Soundarrajan, Ganga Parameshwari; Sharma, P. S.V.N.

In: Journal of Clinical and Diagnostic Research, Vol. 12, No. 2, 01.02.2018, p. FR01-FR02.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Sodium valproate induced hyperammonaemia without hepatic failure in adults

T2 - A series of three cases

AU - Krishna, Vybhav

AU - Thomson, Sereen Rose

AU - Chogtu, Bharti

AU - Soundarrajan, Ganga Parameshwari

AU - Sharma, P. S.V.N.

PY - 2018/2/1

Y1 - 2018/2/1

N2 - Valproate is an antiepileptic drug that is most commonly prescribed because of its wide spectrum of antiepileptic activity. It is used for the treatment of many psychiatric conditions such as bipolar disorder, schizoaffective disorder, social phobias etc. Valproate is associated with modest elevation of plasma ammonia levels. Some of the risk factors associated with this are poor nutritional intake, antiepileptic polypharmacy, febrile conditions which are thought to deplete L-carnitine levels. Hence, it is important to monitor the plasma ammonia levels at intervals before the patient could develop hyperammonaemic encephalopathy. We hereby report a series of three cases of patients who developed hyperammonaemia following the intake of sodium valproate.

AB - Valproate is an antiepileptic drug that is most commonly prescribed because of its wide spectrum of antiepileptic activity. It is used for the treatment of many psychiatric conditions such as bipolar disorder, schizoaffective disorder, social phobias etc. Valproate is associated with modest elevation of plasma ammonia levels. Some of the risk factors associated with this are poor nutritional intake, antiepileptic polypharmacy, febrile conditions which are thought to deplete L-carnitine levels. Hence, it is important to monitor the plasma ammonia levels at intervals before the patient could develop hyperammonaemic encephalopathy. We hereby report a series of three cases of patients who developed hyperammonaemia following the intake of sodium valproate.

UR - http://www.scopus.com/inward/record.url?scp=85043314476&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043314476&partnerID=8YFLogxK

U2 - 10.7860/JCDR/2018/30892.11221

DO - 10.7860/JCDR/2018/30892.11221

M3 - Article

VL - 12

SP - FR01-FR02

JO - Journal of Clinical and Diagnostic Research

JF - Journal of Clinical and Diagnostic Research

SN - 2249-782X

IS - 2

ER -